MedTrace Logo

Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder

NCT02006719 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 322

Last updated 2017-10-05

Study results available
· View outcomes & findings →

Summary

The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.

Conditions

  • Adhesive Capsulitis
  • Frozen Shoulder

Interventions

BIOLOGICAL

Collagenase Clostridium Histolyticum

Treatment of Adhesive Capsulitis

OTHER

Placebo

Placebo injection

Sponsors & Collaborators

  • Endo Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Neil H Schusterman, MD FACP · Endo Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02006719 on ClinicalTrials.gov